Khire Uday 13D/13G Filings for Pasithea Therapeutics Corp. (KTTA)

Khire Uday 13D and 13G filings for Pasithea Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-01-13
08:02 am
Sale
2022-12-3113GPasithea Therapeutics Corp.
KTTA
Khire Uday61,405
4.600%
-12,228decrease
(-16.61%)
Filing
2022-10-20
11:11 am
Purchase
2022-10-1113GPasithea Therapeutics Corp.
KTTA
Khire Uday73,633
5.000%
73,633increase
(New Position)
Filing